ALVITYL Vitalité comprimé à avaler
Food supplement declared in France, declaration No 2018-6-599, decision dated 19 June 2018
ALVITYL Vitalité comprimé à avaler, from LABORATOIRES URGO HEALTHCARE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Pantothenic acid (vitamin B5), Biotin (vitamin B8), Chromium, Copper, Iron. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- ALVITYL
- Food business operator placing the product on the market
- LABORATOIRES URGO HEALTHCARE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 1 comprimé par jour
- Directions for use
- à partir de 6ans : 1 comprimé par jour, à avaler avec un grand verre d'eau (250ml)
- Objectives stated by the manufacturer (these are not authorised claims)
- Growth and development, Bones
- Flavourings
- goût chocolat
Declaration 208529, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothenate, calcium | Pantothenic acid (vitamin B5) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| D-biotin | Biotin (vitamin B8) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| Chlorure de chrome | Chromium | no limit (insufficient data) | 25 µg |
| cupric sulphate | Copper | 5,000 µg | 2,000 µg |
| ferrous sulphate | Iron | 40 mg (safe level) | 14 mg |
| pteroylmonoglutamic acid | Folate (vitamin B9) | 1,000 µg | 200 µg |
| magnesium oxide | Magnesium | 250 mg | 300 mg |
| manganese sulphate | Manganese | 8 mg (safe level) | 3.5 mg |
| Molybdate de sodium | Molybdenum | 600 µg | 150 µg |
| nicotinamide | Nicotinamide (vitamin B3) | 900 mg | 54 mg |
| sodium selenite | Selenium | 255 µg | 50 µg |
| retinyl acetate | Vitamin A | 3,000 µg d'équivalent rétinol | 800 µg |
| thiamin mononitrate | Vitamin B1 (thiamine) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| cyanocobalamin | Vitamin B12 | no adverse effect defined | dose annulled by the French Council of State in 2011 |
| riboflavin | Vitamin B2 (riboflavin) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| pyridoxine hydrochloride | Vitamin B6 | 12 mg | 2 mg |
| L-ascorbic acid | Vitamin C | no limit (insufficient data) | 180 mg |
| cholecalciferol | Vitamin D | 100 µg (4,000 IU) | 5 µg (200 IU) |
| DL-alpha-tocopheryl acetate | Vitamin E | 300 mg | 30 mg |
| zinc oxide | Zinc | 25 mg | 15 mg |
Additives
E553b, E904, E414, E172, E903, E570
Other ingredients
amidon de maïs, saccharose, maltodextrine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : ALVITYL
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “ALVITYL Vitalité comprimé à avaler: composition and regulation”, https://compoatlas.com/en/supplements/products/208529-alvityl-vitalite-comprime-a-avaler, updated 15 November 2026.